Page 3 - Genetic Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bloomsbury Genetic Therapies launches with $5 5 Million in Seed Financing

Bloomsbury Genetic Therapies launches with $5 5 Million in Seed Financing
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Adrien lemoineTechnology fundGenetic therapies

Vertex Pharma (VRTX) Reports New Data from VX-880 Phase 1/2 Trial

Vertex Pharma (VRTX) Reports New Data from VX-880 Phase 1/2 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew orleansCamillo ricordiBastiano sannaJames markmannEuropean association for the study of diabetesDiabetes research instituteSteering committeeCell transplant centerAmerican diabetes associationDivision of transplant surgery at massachusettsUniversity of miami miller school medicineVertex pharmaceuticals incorporated nasdaqWall streetPharmaceuticals incorporatedEuropean association

Weekly Life Science News Round Up: 16th – 20th May

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 16th-20th May.

United statesBeckley psytechDelsitech ltdSosei group corporationShionogi co ltdJeffrey leiden centerCugene incJanssen pharmaceutical companies of johnsonGilead sciences incEmpatica incVertex pharmaceuticals incorporatedCg ltdClinical researchAnticancer bioscience ltdSernova corpLife science

Vertex Pharmaceuticals To Build Additional 344,000 Sq Ft Manufacturing Facility In Boston

At a dedication today of the new Jeffrey Leiden Center for Cell and Genetic Therapies in Boston’s Seaport, Vertex Pharmaceuticals Incorporated.

United statesUnited kingdomCity ofReshma kewalramaniVertex foundationJeffrey leiden centerBoston real estate inclusion fundLeiden center expansionVertex pharmaceuticals incorporated nasdaqLeiden centerGenetic therapiesVertex pharmaceuticals incorporatedExecutive chairmanJeffrey leidenRelated bealReal estate inclusion fund

Vertex Announces Further Expansion in the Boston Seaport at Dedication of the Jeffrey Leiden Center for Cell and Genetic Therapies

At a dedication today of the new Jeffrey Leiden Center for Cell and Genetic Therapies in Boston’s Seaport, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced plans to build another 344,000 square foot facility in the Seaport to support the company’s continued rapid growth, in particular the expansion of .

United statesUnited kingdomCity ofReshma kewalramaniVertex foundationJeffrey leiden centerBoston real estate inclusion fundLeiden center expansionVertex pharmaceuticals incorporated nasdaqGenetic therapiesVertex pharmaceuticals incorporatedLeiden centerExecutive chairmanJeffrey leidenRelated bealKavanagh advisory